← Evidence map

ReviewIntegrative cancer therapies

Efficacy and Safety of Huachansu as an Adjuvant Therapy for Non-Small Cell Lung Cancer: An Overview of Systematic Reviews and Meta-Analyses.

Tiantian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
trialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38469799